Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

Summary

The primary objective is to demonstrate that the Rotigotine transdermal patch is efficacious in Chinese subjects with early-stage idiopathic Parkinson's disease.

Timeline

Start

2012-07

Primary completion

2014-05

Completion

2014-05

Outcome

Met primary endpoint

registry analysis (superiority or other test); Rotigotine vs Placebo; p <0.0001; LS Means -4.82 (95% CI -7.18 to -2.45); ANCOVA NCT01646268 ↗

Drugs

Indications